Xin Li

机构：Tianjin First Center Hospital, Tianjin Medical University · ORCID：0000-0002-7666-1556

发表论文 5 篇 · 总被引 15 次 · h-index 2

代表论文

• A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient (2022 · Cell Transplantation · 被引 10)
• Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects (2024 · Cell Transplantation · 被引 4)
• An exploration of the initiation time and patient selection of PD-1 inhibitors/PD-1 inhibitors combined with chemotherapy as salvage therapy in R/R DLBCL patients after anti-CD19-CAR T-cell therapy (2025 · Cell Transplantation · 被引 1)
• Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR ‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages (2026 · Journal of Cellular and Molecular Medicine)
• COVID ‐19 Infection Confirmed by Bronchoalveolar Lavage Fluid Metagenomics ‐Next‐Generation Sequencing Instead of Pharyngeal Swabs in Follicular Lymphoma: Three‐Case Report and Literature Review (2025 · Journal of Clinical Laboratory Analysis)